Description
Latin name
Totema
Release form
The solution for oral administration is dark brown, with a characteristic odor, a slight precipitate is possible.
Packaging
10 ml – double-ended ampoules of type III yellow glass (10) – cardboard pallets (2) – cardboard packs.
¤ °Ñ ¼ ° º ¾ » ¾ ³ ¸Ñ Ñ º ¾ ´ ¹ÑÑ ² ¸
¾ ¼ ± ¸ ½ ¸Ñ ¾ ² ° ½ ½ ¹ ° ½Ñ ¸ ° ½ ¼ ¸Ñ Ñ º ¸ ¹ ¿Ñ ¿ °Ñ °Ñ .
¡ ¾ ´ Ñ ¶ ¸Ñ ¶ » · ¾, º ¾Ñ ¾Ñ ¾ ½ ¾ ±Ñ ¾ ´ ¸ ¼ ¾ ´ »Ñ Ñ ¸ ½Ñ · ° ³ ¼ °, ²Ñ ¾ ´ÑÑ ³ ¾ ² Ñ ¾ÑÑ ° ² ³ ¼ ¾ ³ » ¾ ± ¸ ½ °, ¼ ¸ ¾ ³ » ¾ ± ¸ ½ °, Ñ » ° ² ¾ ¿Ñ ¾Ñ ¸ ½ ¾ ², º ¾ ¼ ¿ » ºÑ ¾ ² ¶ » · ¾-Ñ Ñ Ñ ¸Ñ ¸ ½ ¸ ¶ » · ¾-Ñ Ñ ° ½ÑÑ Ñ Ñ ¸ ½, Ñ ° · » ¸Ñ ½ Ñ Ñ Ñ ¼ ½Ñ ¾ ² ÑÑ °ÑÑ ²Ñ Ñ ² Ñ Ñ ´ ¾ º ¸Ñ » ¸Ñ »Ñ ½ ¾- ² ¾ÑÑÑ ° ½ ¾ ² ¸Ñ »Ñ ½ Ñ Ñ ° ºÑ ¸ ¹.
´Ñ ¸ ¼ °Ñ ³ ° ½ Ñ ¾Ñ ½ ¾ÑÑÑ ÑÑ º ¼ ¸ ºÑ ¾Ñ » ¼ ½Ñ ° ¼ ¸ Ñ ² »ÑÑÑ ÑÑ º ¾Ñ ° ºÑ ¾Ñ ° ¼ ¸ ½ º ¾Ñ ¾Ñ Ñ Ñ Ñ ¼ ½Ñ ¾ ². Ñ °Ñ ² ° ½ ¸ ¼ ¸ ºÑ ¾Ñ » ¼ ½Ñ ¾ ² ¿Ñ ¾Ñ ¾ ´ ¸Ñ Ñ ¼ ¸ ½Ñ ½Ñ ¸ ² ½ , Ñ ¼ ± ¾ »ÑÑ ´ Ñ ¸Ñ ¸Ñ ¶ » · ° ² ¾Ñ ³ ° ½ ¸ · ¼ .
Ñ ¸ ¿Ñ ¸ ¼ ¿Ñ ¿ °Ñ °Ñ ° ¿Ñ ¾ ¸ÑÑ ¾ ´ ¸Ñ ¿ ¾ÑÑ ¿ ½ ½ °Ñ Ñ ³Ñ ÑÑ ¸Ñ º » ¸ ½ ¸Ñ Ñ º ¸Ñ ¸ » ° ± ¾Ñ °Ñ ¾Ñ ½ Ñ Ñ ¸ ¼ ¿Ñ ¾ ¼ ¾ ² ° ½ ¼ ¸ ¸.
¤ °Ñ ¼ ° º ¾ º ¸ ½ Ñ ¸ º °
Ñ °Ñ ² ° ½ ¸ ¶ » · ° ¸ ´Ñ Ñ ³ ¸Ñ ¼ ¸ ºÑ ¾Ñ » ¼ ½Ñ ¾ ² ¿Ñ ¾ ¸ÑÑ ¾ ´ ¸Ñ ¿Ñ ¸ ¼ÑÑ ÑÑ ² ½ ½ ¾ ² ´ ² ½ ° ´Ñ °Ñ ¸ ¿ Ñ ÑÑ ½ ¾ ¹ º ¸Ñ º ¸ ² Ñ Ñ ½ ¼ ¾Ñ ´ » Ñ ¾Ñ ¹ º ¸Ñ º ¸.
Indications
Treatment and prevention of iron deficiency anemia in adults and children from 3 months of age, caused by various reasons: bleeding
increased iron demand (pregnancy)
insufficient intake of iron from food or impaired absorption.
Contraindications
anemia not associated with iron deficiency
hemochromatosis, hemosiderosis
thalassemia
gastric ulcer and duodenal ulcer disease, acute phase
intoxication, lead to somnocomial syndrome malabsorption of glucose galactose
children under 3 months of age
hypersensitivity to the components of the drug.
Caution is advised to prescribe the drug for diabetes.
Use in children
Contraindication: children under 3 months of age.
Use during pregnancy and lactation
Use of the drug during pregnancy and lactation is allowed according to the indications in recommended doses.
Composition
1 amp.
iron (elemental, in the form of iron gluconate dihydrate) 50 mg
manganese (elemental, in the form of manganese gluconate) 1.33 mg
copper (elemental, in the form of copper gluconate) 700 mcg
Excipients: glycerol – 2.52 g, dextrose – 80 mg, sucrose – 3 g, anhydrous citric acid – 27.4 mg, sodium citrate dihydrate – 30 mg, sodium benzoate – 20 mg, polysorbate 80 – 24 mg, TPS caramel color (E150c) – 50 mg, tutti-frutti flavor – 20 μl, purified water – up to 10 ml.
Dosage and administration of
For the treatment of anemia, adults are prescribed a drug at the rate of 100-200 mg of iron (2-4 amp.) / day for children older than 3 months – at the rate of 5-7 mg / kg body weight / day in 2-4 reception.
The use of the drug is carried out under the control of the content of iron in blood serum, the total iron-binding ability of the serum before treatment and subsequently with a frequency of 1 time in 2 months.
For preventive purposes, adults and pregnant women (starting from the 4th month of pregnancy) are prescribed 50 mg (1 amp.) / day. For children, depending on age, the drug is prescribed in a dose of 1/4 to 1/2 daily therapeutic dose for adults.
Duration of treatment is determined individually. The average duration of taking the drug is from 3 to 6 months (before the restoration of iron stores in the body).
Terms of use of the drug
Shake well before use.
You should tear off a piece of cardboard from the bundle along the dotted line, bend it in half to safely break the tip of the ampoule. Break the vial on both sides, pour the contents of the vial into a glass, dissolve in plain or sweetened water.
Take orally, before eating.
Side effects of the
Digestive system:
staining black feces (is the norm)
heartburn nausea
vomiting
diarrhea
constipation
epigastric pain
darkening of tooth enamel.
Other: allergic reactions.
Drug Interaction
Co-administration of Totem ® leads to a decrease in the absorption of bisphosphonates, ciprofloxacin, tetracyclines when taken orally.
Magnesium, aluminum and calcium salts, oxides and hydroxides disrupt the absorption of iron salts. Totem ® should be taken no earlier than 2 hours after taking these drugs.
It is impossible to combine the drug with other iron preparations, incl. administered parenterally.
Overdose
Symptoms: weakness, hyperthermia, convulsions, nausea, vomiting, constipation, diarrhea, epigastric pain. The cases of necrosis of the walls of the gastrointestinal tract and shock are described.
Treatment: gastric lavage with 1% sodium bicarbonate (baking soda). When the concentration of iron in the serum of more than 5 μg / ml, enter Deferoxamine in / slowly: children – 15 mg / kg / h, adults – 5 mg / kg / h (up to 80 mg / kg / day) with mild poisoning / m : children – 1 g every 4-6 h, adults – 50 mg / kg (up to 4 g / day) spend symptomatic therapy in case of shock, conduct anti-shock therapy.
Storage conditions
The drug should be stored out of the reach of children at a temperature not exceeding 25 ° C.
Expiration
2 Year
Active ingredient
Iron gluconate, Manganese gluconate, Copper gluconate
Terms of delivery from
pharmacies Prescription
solution dosage form for oral dosage
Innotek Internasionaly, France